Efficacy and Safety of Valdecoxib and Naproxen in Treating the Signs and Symptoms of Rheumatoid Arthritis (RA) in a Severe Rheumatoid Arthritis Patients

Clinical trial NCT00650455 · COMPLETED

Trial details

NCT number: NCT00650455
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Arthritis, Rheumatoid

Start date: 2003-02-01
Primary completion: 2005-01-01
Enrollment: 489

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.